Brief: Windtree Therapeutics Announces New Corporate Strategy
08/01/2025 14:02
Jan 8 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS ANNOUNCES NEW CORPORATE STRATEGY
SEEKING
TO IDENTIFY AND ACQUIRE FDA-APPROVED REVENUE ASSETS WHILE
ADVANCING ITS CARDIOVASCULAR AND ONCOLOGY PIPELINE
* WINDTREE THERAPEUTICS INC - TO ACQUIRE STRATEGIC
SUBSIDIARIES
WITH FDA-APPROVED PRODUCTS
* WINDTREE THERAPEUTICS INC - TO USE EQUITY FOR ACQUISITIONS
Source text: urn:newsml:reuters.com:*:nGNX15G7l0
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study